bluebird bio, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
bluebird bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2012 to Q2 2024.
  • bluebird bio, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $21K.
  • bluebird bio, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$25K, a 168% decline year-over-year.
  • bluebird bio, Inc. annual Income Tax Expense (Benefit) for 2023 was -$126K, a 208% decline from 2022.
  • bluebird bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $117K, a 54.7% decline from 2021.
  • bluebird bio, Inc. annual Income Tax Expense (Benefit) for 2021 was $258K, a 62.4% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$25K $21K +$101K Apr 1, 2024 Jun 30, 2024 10-Q 2024-09-27
Q1 2024 -$126K $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-13
Q4 2023 -$126K -$46K -$156K -142% Oct 1, 2023 Dec 31, 2023 10-K 2024-09-13
Q3 2023 $30K $0 -$7K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $37K -$80K -$80K Apr 1, 2023 Jun 30, 2023 10-Q 2024-09-27
Q1 2023 $117K $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-09-13
Q4 2022 $117K $110K +$21K +23.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-09-13
Q3 2022 $96K $7K +$120K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$24K $0 -$216K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $192K $0 -$66K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $258K $89K -$164K -64.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $422K -$113K -$442K -134% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $864K $216K +$206K +2060% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $658K $66K -$28K -29.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $686K $253K +$50K +24.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-29
Q3 2020 $636K $329K +$593K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $43K $10K +$479K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$436K $94K +$109K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$545K $203K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-04
Q3 2019 -$264K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$469K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$15K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2016 -$612K -$63K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-21
Q3 2016 -$178K -$238K -397% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$226K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$145K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q3 2015 $60K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2014 -$11.8M -$11.8M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 $0 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-13
Q3 2013 $0 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $0 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.